Burkina Faso vs Sao Tome and Principe: Share of one-year-olds vaccinated against rotavirus
Burkina Faso
87.0%
in 2024
Sao Tome and Principe
87.0%
in 2024
Burkina Faso rank
38th
Sao Tome and Principe rank
38th
Share of one-year-olds vaccinated against rotavirus over time
- Burkina Faso
- Sao Tome and Principe
How they compare
Burkina Faso currently reports 87.0% against 87.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 3 times across 9 shared years of data; in 2016 it was Burkina Faso ahead.
Burkina Faso ranks 38th and Sao Tome and Principe ranks 38th of 108 countries.
Burkina Faso has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.0% | 77.2% | 13.8% | Burkina Faso |
| 2020s | 86.2% | 76.8% | 9.4% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against rotavirus, Burkina Faso or Sao Tome and Principe?
- Burkina Faso, at 87.0% against 87.0% in Sao Tome and Principe as of 2024.
- What is the difference in share of one-year-olds vaccinated against rotavirus between Burkina Faso and Sao Tome and Principe?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Sao Tome and Principe?
- 9 years are reported by both, from 2016 to 2024.
- How do Burkina Faso and Sao Tome and Principe rank globally for share of one-year-olds vaccinated against rotavirus?
- Burkina Faso ranks 38th and Sao Tome and Principe ranks 38th of 108 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against rotavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the final recommended dose (2nd or 3rd) of the rotavirus vaccine in a given year.